DXCM vs. MDT: DexCom vs. Medtronic Stock Comparison
How do DexCom (DXCM) and Medtronic (MDT) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
DexCom (DXCM) and Medtronic (MDT) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | DXCM | MDT |
|---|---|---|
| Name | DexCom Inc. | Medtronic plc |
| Country/Region | United States | Ireland |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 29.62 billion USD | 130.22 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | April 14, 2005 | May 2, 1973 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | DXCM | MDT |
|---|---|---|
| Total Return (1Y) | 46.33% | 15.72% |
| Total Return (3Y, Annualized) | -4.50% | 17.58% |
| Total Return (5Y, Annualized) | -12.76% | -0.18% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
DexCom (DXCM) has an aggressive beta of 1.43, indicating higher sensitivity to broad-market moves, while Medtronic (MDT) is defensive at 0.53 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.
| Metric | DXCM | MDT |
|---|---|---|
| Volatility (1Y, Annualized) | 38.37% | 25.84% |
| Beta (5Y) | 1.43 | 0.53 |
| Max Drawdown (5Y) | -66.32% | -39.67% |
| Avg. Volume (3M) | 4.34M | 16.48M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | DXCM | MDT |
|---|---|---|
| Sharpe Ratio (1Y) | 1.10 | 0.44 |
| Sortino Ratio (1Y) | 1.79 | 0.71 |
Profitability
ROE (TTM)
DexCom (DXCM) at 37.67% sits in the top ROE quartile, while Medtronic (MDT) at 10.65% is closer to the peer norm — stronger capital efficiency for DXCM.
DXCM
Health Care Equipment & Services industry group
37.67%
- Max
- 47.61%
- DXCM
- 37.67%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
MDT
Health Care Equipment & Services industry group
10.65%
- Max
- 47.61%
- Q3
- 14.36%
- MDT
- 10.65%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both DexCom (DXCM) at 19.42% and Medtronic (MDT) at 13.93% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
DXCM
Health Care Equipment & Services industry group
19.42%
- Max
- 29.35%
- DXCM
- 19.42%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
MDT
Health Care Equipment & Services industry group
13.93%
- Max
- 29.35%
- MDT
- 13.93%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both DexCom (DXCM) at 24.34% and Medtronic (MDT) at 19.33% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
DXCM
Health Care Equipment & Services industry group
24.34%
- Max
- 35.43%
- DXCM
- 24.34%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
MDT
Health Care Equipment & Services industry group
19.33%
- Max
- 35.43%
- MDT
- 19.33%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | DXCM | MDT |
|---|---|---|
| ROE (TTM) | 37.67% | 10.65% |
| ROA (TTM) | 11.14% | 5.12% |
| Net Margin (TTM) | 19.42% | 13.93% |
| Operating Margin (TTM) | 24.34% | 19.33% |
| Gross Margin (TTM) | 63.42% | 65.27% |
Growth
Revenue Growth
Both DexCom (DXCM) at 15.60% and Medtronic (MDT) at 8.43% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
DexCom (DXCM) at 47.18% sits in the top EPS growth quartile, while Medtronic (MDT) at 3.32% is closer to the peer norm — faster per-share earnings growth for DXCM.
Growth Metrics
| Metric | DXCM | MDT |
|---|---|---|
| Revenue Growth (YoY) | 15.60% | 8.43% |
| Revenue Growth (3Y CAGR) | 17.01% | 5.21% |
| EPS Growth (YoY) | 47.18% | 3.32% |
| EPS Growth (3Y CAGR) | 36.60% | 9.77% |
Financial Strength
Current Ratio (MRQ)
Both DexCom (DXCM) at 1.74 and Medtronic (MDT) at 2.07 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
DXCM
Health Care Equipment & Services industry group
1.74
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DXCM
- 1.74
- Q1
- 1.37
- Min
- 0.30
MDT
Health Care Equipment & Services industry group
2.07
- Max
- 7.59
- Q3
- 4.00
- MDT
- 2.07
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both DexCom (DXCM) at 0.55 and Medtronic (MDT) at 0.55 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
DXCM
Health Care Equipment & Services industry group
0.55
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- DXCM
- 0.55
- Q1
- 0.16
- Min
- 0.00
MDT
Health Care Equipment & Services industry group
0.55
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- MDT
- 0.55
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | DXCM | MDT |
|---|---|---|
| Current Ratio (MRQ) | 1.74 | 2.07 |
| Debt / Equity (MRQ) | 0.55 | 0.55 |
| Net Debt / EBITDA | -0.28 | 1.86 |
Dividends
Dividend Yield (TTM)
DexCom (DXCM) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Medtronic (MDT) reports a yield of 2.72%, ranking against industry peers normally.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
MDT
Health Care Equipment & Services industry group
2.72%
- MDT
- 2.72%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
DexCom (DXCM) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Medtronic (MDT) reports a payout of 70.02%, ranking against industry peers normally.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
MDT
Health Care Equipment & Services industry group
70.02%
- MDT
- 70.02%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | DXCM | MDT |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 2.72% |
| Dividend Payout Ratio (TTM) | 0.00% | 70.02% |
Valuation
P/E Ratio (TTM)
Both DexCom (DXCM) at 31.26 and Medtronic (MDT) at 25.01 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
DXCM
Health Care Equipment & Services industry group
31.26
- Max
- 80.41
- Q3
- 47.62
- DXCM
- 31.26
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
MDT
Health Care Equipment & Services industry group
25.01
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- MDT
- 25.01
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Medtronic (MDT) at 3.47 is priced about in line with its industry on P/S ratio, while DexCom (DXCM) at 5.80 sits in the pricier quartile — DXCM costs more per dollar of sales.
DXCM
Health Care Equipment & Services industry group
5.80
- Max
- 8.80
- DXCM
- 5.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
MDT
Health Care Equipment & Services industry group
3.47
- Max
- 8.80
- Q3
- 4.32
- MDT
- 3.47
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Medtronic (MDT) at 2.59 is valued about in line with its industry on P/B ratio, while DexCom (DXCM) at 11.68 carries an above-peer premium to book — DXCM is pricier on assets.
DXCM
Health Care Equipment & Services industry group
11.68
- DXCM
- 11.68
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
MDT
Health Care Equipment & Services industry group
2.59
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- MDT
- 2.59
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | DXCM | MDT |
|---|---|---|
| P/E Ratio (TTM) | 31.26 | 25.01 |
| P/S Ratio (TTM) | 5.80 | 3.47 |
| P/B Ratio (MRQ) | 11.68 | 2.59 |
| Free Cash Flow Yield (TTM) | 2.74% | 4.16% |